Jeffrey J. Weiss

1.2k total citations
44 papers, 806 citations indexed

About

Jeffrey J. Weiss is a scholar working on Epidemiology, Hepatology and Infectious Diseases. According to data from OpenAlex, Jeffrey J. Weiss has authored 44 papers receiving a total of 806 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Epidemiology, 15 papers in Hepatology and 9 papers in Infectious Diseases. Recurrent topics in Jeffrey J. Weiss's work include Hepatitis C virus research (15 papers), Liver Disease Diagnosis and Treatment (9 papers) and HIV/AIDS Research and Interventions (7 papers). Jeffrey J. Weiss is often cited by papers focused on Hepatitis C virus research (15 papers), Liver Disease Diagnosis and Treatment (9 papers) and HIV/AIDS Research and Interventions (7 papers). Jeffrey J. Weiss collaborates with scholars based in United States, Netherlands and United Kingdom. Jeffrey J. Weiss's co-authors include Allan Geliebter, Dawn Fishbein, Linda Wang, Jack M. Gorman, Norbert Bräu, Karl Goodkin, Michael H. Antoni, Sue M. Marcus, Tracy Swan and Elizabeth Ryan and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Hepatology and Journal of General Internal Medicine.

In The Last Decade

Jeffrey J. Weiss

43 papers receiving 771 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jeffrey J. Weiss United States 15 253 225 194 157 153 44 806
Jeannette E. South-Paul United States 15 86 0.3× 141 0.6× 376 1.9× 44 0.3× 51 0.3× 31 897
Omar T. Sims United States 12 73 0.3× 152 0.7× 120 0.6× 41 0.3× 127 0.8× 59 483
Barbara Coughlan Ireland 17 145 0.6× 187 0.8× 158 0.8× 11 0.1× 155 1.0× 58 845
Iheb Bougmiza Tunisia 17 113 0.4× 182 0.8× 125 0.6× 126 0.8× 13 0.1× 98 843
Gregory Patts United States 15 87 0.3× 156 0.7× 49 0.3× 134 0.9× 28 0.2× 35 467
J Chwalow France 12 42 0.2× 139 0.6× 85 0.4× 112 0.7× 101 0.7× 23 554
Kristen E. Gray United States 17 173 0.7× 112 0.5× 197 1.0× 12 0.1× 67 0.4× 53 991
Francisco Cumsille Chile 15 52 0.2× 471 2.1× 96 0.5× 192 1.2× 117 0.8× 61 962
Amanda L. Willig United States 20 116 0.5× 190 0.8× 281 1.4× 342 2.2× 11 0.1× 70 1.3k
Barbara Bell Australia 15 92 0.4× 115 0.5× 122 0.6× 45 0.3× 77 0.5× 56 959

Countries citing papers authored by Jeffrey J. Weiss

Since Specialization
Citations

This map shows the geographic impact of Jeffrey J. Weiss's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeffrey J. Weiss with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeffrey J. Weiss more than expected).

Fields of papers citing papers by Jeffrey J. Weiss

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jeffrey J. Weiss. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeffrey J. Weiss. The network helps show where Jeffrey J. Weiss may publish in the future.

Co-authorship network of co-authors of Jeffrey J. Weiss

This figure shows the co-authorship network connecting the top 25 collaborators of Jeffrey J. Weiss. A scholar is included among the top collaborators of Jeffrey J. Weiss based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeffrey J. Weiss. Jeffrey J. Weiss is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wisnivesky, Juan P., Adam Gonzalez, Paula J. Busse, et al.. (2023). World Trade Center workers with asthma and post-traumatic stress disorder perceive airflow limitation more accurately. Annals of Allergy Asthma & Immunology. 132(1). 62–68. 1 indexed citations
2.
Shander, Aryeh, et al.. (2021). Deploying Health Care Providers During the COVID-19 Pandemic. Disaster Medicine and Public Health Preparedness. 16(6). 2669–2672. 2 indexed citations
3.
Sigel, Keith, et al.. (2021). Community Case Study of Naloxone Distribution by Hospital-Based Harm Reduction Program for People Who Use Drugs in New York City. Frontiers in Sociology. 6. 619683–619683. 7 indexed citations
4.
Dunham, Katherine, et al.. (2021). Transitioning Clinical Care for People Who Use Drugs to Telemedicine: Lessons Learned One Year into the COVID-19 Pandemic. Telemedicine Journal and e-Health. 27(8). 929–933. 7 indexed citations
5.
Oster, Scott, et al.. (2021). Predictors of hepatitis C treatment outcomes in a harm reduction-focused primary care program in New York City. Harm Reduction Journal. 18(1). 38–38. 8 indexed citations
6.
Barbosa, Peter, et al.. (2020). Empathy in Podiatric Medical Education: Challenges and Opportunities for Comprehensive Care. Journal of the American Podiatric Medical Association. 110(5). 3 indexed citations
7.
Weiss, Jeffrey J., et al.. (2020). Herpes-zoster associated urinary retention in a 57-year-old immunocompromised male. Urology Case Reports. 34. 101498–101498. 2 indexed citations
8.
Gardenier, Donald, et al.. (2019). Interprofessional team-based approach to patients with chronic hepatitis C and personality disorder: Three case studies. Archives of Psychiatric Nursing. 33(4). 352–357. 1 indexed citations
9.
Behrends, Czarina N., Ashley A. Eggman, Sarah Gutkind, et al.. (2018). A Cost Reimbursement Model for Hepatitis C Treatment Care Coordination. Journal of Public Health Management and Practice. 25(3). 253–261. 8 indexed citations
10.
Kamath, Geetanjali R., Emanuela Taioli, Natalia Egorova, et al.. (2018). Liver Cancer Disparities in New York City: A Neighborhood View of Risk and Harm Reduction Factors. Frontiers in Oncology. 8. 13 indexed citations
11.
Weiss, Jeffrey J., Ioannis Konstantinidis, Daniel S. Fierer, et al.. (2016). Illness Perceptions, Medication Beliefs, and Adherence to Antiretrovirals and Medications for Comorbidities in Adults With HIV Infection and Hypertension or Chronic Kidney Disease. JAIDS Journal of Acquired Immune Deficiency Syndromes. 73(4). 403–410. 14 indexed citations
12.
13.
Mattocks, Kristin, Anne G. Sadler, Elizabeth M. Yano, et al.. (2013). Sexual Victimization, Health Status, and VA Healthcare Utilization Among Lesbian and Bisexual OEF/OIF Veterans. Journal of General Internal Medicine. 28(S2). 604–608. 58 indexed citations
14.
Zhang, Jianping, Jeffrey J. Weiss, Lawrence Maayan, et al.. (2012). Effectiveness of a Cognitive Behavioral Weight Management Intervention in Obese Patients With Psychotic Disorders Compared to Patients With Nonpsychotic Disorders or No Psychiatric Disorders. Journal of Clinical Psychopharmacology. 32(4). 458–464. 10 indexed citations
15.
Weiss, Jeffrey J., et al.. (2010). Prevalence and Patient Awareness of Medical Comorbidities in an Urban AIDS Clinic. AIDS Patient Care and STDs. 24(1). 39–48. 41 indexed citations
16.
Weiss, Jeffrey J., et al.. (2009). Review article: adherence to medication for chronic hepatitis C – building on the model of human immunodeficiency virus antiretroviral adherence research. Alimentary Pharmacology & Therapeutics. 30(1). 14–27. 41 indexed citations
17.
Weiss, Jeffrey J. & Susan Morgello. (2009). Psychiatric management of HIV/HCV-coinfected patients beginning treatment for hepatitis C virus infection: survey of provider practices. General Hospital Psychiatry. 31(6). 531–537. 4 indexed citations
18.
Weiss, Jeffrey J. & Jack M. Gorman. (2006). Psychiatric behavioral aspects of comanagement of hepatitis C virus and HIV. Current HIV/AIDS Reports. 3(4). 176–181. 21 indexed citations
19.
Cohen, Mary Ann, et al.. (2003). Treatment of Interferon-Induced Psychosis in Patients With Comorbid Hepatitis C and HIV. Psychosomatics. 44(5). 417–420. 14 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jeannette E. South-Paul Breakdown of academic impact, for papers by Omar T. Sims Breakdown of academic impact, for papers by Barbara Coughlan Breakdown of academic impact, for papers by Iheb Bougmiza Breakdown of academic impact, for papers by Gregory Patts Breakdown of academic impact, for papers by J Chwalow Breakdown of academic impact, for papers by Kristen E. Gray Breakdown of academic impact, for papers by Francisco Cumsille Breakdown of academic impact, for papers by Amanda L. Willig Breakdown of academic impact, for papers by Barbara Bell
Rankless by CCL
2026